Identification of salinity responsive genes in lavender by means of cDNA-AFLP
- Presently, a world demand exists forlavender as a giant medicinal plant and provide of necessary oils. Freshwater and arable lands are two primary components that inhibit intensive farming of medicinal crops in Iran. Saline water from seas and salty soil may be new sources for agricultural use, significantly for medicinal crops.
- We sought to extend our knowledge of the Lavandulaangustifolia genome and molecular basis of its salinity tolerance by way of the usage of cDNA amplified fragment dimension polymorphism (cDNA-AFLP) to research the changes in plant transcriptomes in response to NaCl.
- All acknowledged transcript derived fragments (TDF) have been assigned as novel angustifolia genes related to signal transduction, regulation of gene expression, completely different splicing, autophagy, and secondary metabolite biosynthesis. qRT-PCR analysis of the TDFs in response to utterly completely different concentrations of NaCl revealed diverse ranges of mRNA of the acknowledged genes on this plant.
- Our findings equipped primary insights into the molecular response of angustifolia to salinity.
Orf Virus VEGF-E |
|||
MBS691891-0005mg | MyBiosource | 0.005mg | EUR 350 |
Orf Virus VEGF-E |
|||
MBS691891-5x0005mg | MyBiosource | 5x0.005mg | EUR 1275 |
Orf Virus VEGF-E |
|||
MBS691947-0002mg | MyBiosource | 0.002mg | EUR 265 |
Orf Virus VEGF-E |
|||
MBS691947-5x0002mg | MyBiosource | 5x0.002mg | EUR 890 |
VEGF E (Orf Virus) |
|||
cyt-263 | ProSpec Tany | 2µg | EUR 60 |
Description: Recombinant Vascular Endothelial Growth Factor-E (Orf Virus) |
Orf Virus VEGF-E, Heparin-binding |
|||
MBS691480-002mg | MyBiosource | 0.02mg | EUR 440 |
Orf Virus VEGF-E, Heparin-binding |
|||
MBS691480-5x002mg | MyBiosource | 5x0.02mg | EUR 1685 |
Orf Virus VEGF-E, Heparin-binding |
|||
MBS691994-0005mg | MyBiosource | 0.005mg | EUR 300 |
Orf Virus VEGF-E, Heparin-binding |
|||
MBS691994-5x0005mg | MyBiosource | 5x0.005mg | EUR 1050 |
Orf virus VEGF-E Recombinant Protein |
|||
300-044 | ReliaTech | 5 µg | EUR 136.5 |
Description: A DNA sequence encoding the mature variant of ov-VEGF-E isolate D1701 (Dehio et al., 1999; GenBank accession No. AF106020) was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle et al., 1994). Different isolates of Orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appears to be derived from captured host genes. All eight Cysteine residues of the central Cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins (Dehio et al., 1999; Wise et al., 1999). Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E cannot bind to VEGF receptor-1 (Flt-1). Furthermore VEGF-E can also not bind to VEGF receptor-3 (FLT-4). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor –2/KDR. |
Orf virus VEGF-E Recombinant Protein |
|||
300-044S | ReliaTech | 2 µg | EUR 73.5 |
Description: A DNA sequence encoding the mature variant of ovVEGF-E isolate D1701 (Dehio et al., 1999; GenBank accession No. AF106020) was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle et al., 1994). Different isolates of Orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appears to be derived from captured host genes. All eight cysteine residues of the central cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins (Dehio et al., 1999; Wise et al., 1999). Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E can not bind to VEGF receptor-1 (Flt-1). Furthermore VEGF-E can also not bind to VEGF receptor-3 (FLT-4). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor –2/KDR. |
Orf virus VEGF-E Recombinant Protein |
|||
300-045 | ReliaTech | 20 µg | EUR 357 |
Description: A DNA sequence encoding the mature variant of ovVEGF-E isolate D1701 (Dehio et al., 1999; GenBank accession No. AF106020) was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle et al., 1994). Different isolates of Orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appears to be derived from captured host genes. All eight cysteine residues of the central cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins (Dehio et al., 1999; Wise et al., 1999). Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E can not bind to VEGF receptor-1 (Flt-1). Furthermore VEGF-E can also not bind to VEGF receptor-3 (FLT-4). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor –2/KDR. |
Anti-Orf Virus VEGF-E Antibody |
|||
102-PA70 | ReliaTech | 50 µg | EUR 115.5 |
Description: A DNA sequence encoding the mature variant of ov-VEGF-E isolate D1701 was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV). Different isolates of Orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appears to be derived from captured host genes. All eight Cysteine residues of the central Cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins. Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E cannot bind to VEGF receptor-1 (Flt-1). Furthermore VEGF-E can also not bind to VEGF receptor-3 (FLT-4). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor –2/KDR. |
Recombinant Virus VEGF E (Orf Virus) Protein, His, E.coli-1mg |
|||
QP10912-1mg | EnQuireBio | 1mg | EUR 6181.2 |
Recombinant Virus VEGF E (Orf Virus) Protein, His, E.coli-2ug |
|||
QP10912-2ug | EnQuireBio | 2ug | EUR 186 |
Recombinant Virus VEGF E (Orf Virus) Protein, His, E.coli-10ug |
|||
QP10912-10ug | EnQuireBio | 10ug | EUR 241.2 |
Orf virus VEGF-E, Heparin-binding Recombinant Protein |
|||
300-046 | ReliaTech | 20 µg | EUR 194.25 |
Description: A DNA sequence encoding the first 116 amino acid residue of Orf virus VEGF-E isolate D1701 (Dehio et al., 1999 EMBO J. 18:363-374; GenBank accession No. AF106020) was fused with a DNA sequence encoding to the C-terminal heparin binding domain of human VEGF165. The chimeric protein was expressed in insect cells using a baculovirus expression system. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle et al., 1994 J. Virol 68:84-92). Different isolates of orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appear to be derived from captured host genes. All eight cysteine residues of the central cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins (Dehio et al., 1999 EMBO J. 18:363-374; Wise et al., 1999 Proc. Natl. Acad. Sci USA 96:3071-3076). Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E and hb-VEGF-E can not bind to VEGF receptor-1 (Flt-1). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor–2/ KDR. Compared to human VEGF165 this virus form has no heparin-binding domain and seems to be a freely secreted protein comparable to VEGF121. In order to compare this form with human VEGF165, an additional heparin-binding domain was engineered at the C-terminus to allow interaction with proteo-aminoglycans and heparan sulfate. These form is also able to interact with neuropillin–1. |
Orf virus VEGF-E, Heparin-binding Recombinant Protein |
|||
300-046S | ReliaTech | 5 µg | EUR 94.5 |
Description: A DNA sequence encoding the first 116 amino acid residue of Orf virus VEGF-E isolate D1701 (Dehio et al., 1999 EMBO J. 18:363-374; GenBank accession No. AF106020) was fused with a DNA sequence encoding to the C-terminal heparin binding domain of human VEGF165. The chimeric protein was expressed in insect cells using a baculovirus expression system. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle et al., 1994 J. Virol 68:84-92). Different isolates of orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appear to be derived from captured host genes. All eight cysteine residues of the central cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins (Dehio et al., 1999 EMBO J. 18:363-374; Wise et al., 1999 Proc. Natl. Acad. Sci USA 96:3071-3076). Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E and hb-VEGF-E can not bind to VEGF receptor-1 (Flt-1). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor–2/ KDR. Compared to human VEGF165 this virus form has no heparin-binding domain and seems to be a freely secreted protein comparable to VEGF121. In order to compare this form with human VEGF165, an additional heparin-binding domain was engineered at the C-terminus to allow interaction with proteo-aminoglycans and heparan sulfate. These form is also able to interact with neuropillin–1. |
VEGF-E Vascular Endothelial Growth Factor-E Recombinant Protein(Orf Virus) |
|||
PROTQ2F842 | BosterBio | Regular: 10ug | EUR 380.4 |
Description: A DNA sequence encoding the mature variant of ovVEGF-E isolate D1701 (Dehio et al., 1999; GenBank accession No. AF106020) was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa. |
ov-VEGF-E (Orf virus) (Recombinant) Human |
|||
GWB-C8AD60 | GenWay Biotech | 0.005 mg | Ask for price |
VEGFE protein (Orf virus) |
|||
30R-AV011 | Fitzgerald | 5 ug | EUR 381 |
Description: Purified recombinant VEGFE protein (Orf virus) |
VEGFE protein (Orf virus) |
|||
MBS538323-0005mg | MyBiosource | 0.005mg | EUR 505 |
VEGFE protein (Orf virus) |
|||
MBS538323-5x0005mg | MyBiosource | 5x0.005mg | EUR 2125 |
Recombinant Orf Virus VEGFE Protein |
|||
VAng-Lsx0417-inquire | Creative Biolabs | inquire | Ask for price |
Description: Orf Virus VEGFE, recombinant protein from Baculovirus. |
Recombinant Orf Virus VEGFE Protein [His] |
|||
VAng-Lsx0418-inquire | Creative Biolabs | inquire | Ask for price |
Description: Orf Virus VEGFE [His], recombinant protein from E. coli. |
Deoxybrevianamide E |
|||
D083-1MG | TOKU-E | 1 mg | EUR 187.71 |
Description: C21H25N3O2 |
Deoxybrevianamide E |
|||
D083-5MG | TOKU-E | 5 mg | EUR 656.34 |
Description: C21H25N3O2 |
Berkeleylactone E |
|||
B087-1MG | TOKU-E | 1 mg | EUR 142.63 |
Description: C20H32O7 |
Berkeleylactone E |
|||
B087-5MG | TOKU-E | 5 mg | EUR 498.97 |
Description: C20H32O7 |
Chevalone E |
|||
C257-0.5MG | TOKU-E | 0.5 mg | EUR 150.43 |
Description: C20H24O4 |
Chevalone E |
|||
C257-2.5MG | TOKU-E | 2.5 mg | EUR 525.85 |
Description: C20H24O4 |
Cytochalasin E |
|||
C197-1MG | TOKU-E | 1 mg | EUR 77.6 |
Description: C28H33NO7 |
Cytochalasin E |
|||
C197-5MG | TOKU-E | 5 mg | EUR 270.51 |
Description: C28H33NO7 |
Oligomycin E |
|||
O021-1MG | TOKU-E | 1 mg | EUR 207.65 |
Description: C45H72O13 |
Oligomycin E |
|||
O021-5MG | TOKU-E | 5 mg | EUR 726.13 |
Description: C45H72O13 |
Paraherquamide E |
|||
P070-0.5MG | TOKU-E | 0.5 mg | EUR 265.74 |
Description: C28H35N3O4 |
Paraherquamide E |
|||
P070-2.5MG | TOKU-E | 2.5 mg | EUR 928.58 |
Description: C28H35N3O4 |
Phenelfamycin E |
|||
P078-1MG | TOKU-E | 1 mg | EUR 207.65 |
Description: C65H95NO21 |
Phenelfamycin E |
|||
P078-5MG | TOKU-E | 5 mg | EUR 726.13 |
Description: C65H95NO21 |
Roquefortine E |
|||
R035-1MG | TOKU-E | 1 mg | EUR 146.96 |
Description: C27H31N5O2 |
Roquefortine E |
|||
R035-5MG | TOKU-E | 5 mg | EUR 513.71 |
Description: C27H31N5O2 |
Azithromycin impurity E EvoPure® |
|||
A074-5MG | TOKU-E | 5 mg | EUR 593.04 |
Description: C36H68N2O12 |
Hepatitis E virus ORF 2 recombinant antigen |
|||
8942 | Virostat | 100 ug | EUR 477.6 |
Description: This is Hepatitis E virus ORF 2 recombinant antigen for ELISA,WB. |
Hepatitis E virus ORF 2 recombinant antigen |
|||
8943 | Virostat | 100 ug | EUR 477.6 |
Description: This is Hepatitis E virus ORF 2 recombinant antigen for ELISA,WB. |
Hepatitis E virus ORF 3 recombinant antigen |
|||
8944 | Virostat | 100 ug | EUR 477.6 |
Description: This is Hepatitis E virus ORF 3 recombinant antigen for ELISA,WB. |
Hepatitis E virus ORF 3 Recombinant Protein |
|||
53-335 | ProSci | 0.01 mg | EUR 651.3 |
Description: Hepatitis E virus ORF 3 Recombinant Protein |
Hepatitis E virus ORF 2 Recombinant Protein |
|||
53-336 | ProSci | 0.01 mg | EUR 651.3 |
Description: Hepatitis E virus ORF 2 Recombinant Protein |
Hepatitis E virus ORF 2 Recombinant Protein |
|||
53-337 | ProSci | 0.01 mg | EUR 651.3 |
Description: Hepatitis E virus ORF 2 Recombinant Protein |
Vascular Endothelial Growth Factor-E (Orf Virus) Protein |
|||
20-abx263083 | Abbexa |
|
|
Vascular Endothelial Growth Factor-E (Orf Virus) Protein |
|||
abx263083-10mg | Abbexa | 10 mg | EUR 325 |
Vascular Endothelial Growth Factor-E (Orf Virus) Protein |
|||
abx263083-25mg | Abbexa | 25 mg | EUR 6500 |
Vascular Endothelial Growth Factor-E (Orf Virus) Protein |
|||
abx263083-5mg | Abbexa | 5 mg | EUR 225 |
Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF E) |
|||
MBS1007472-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 990 |
Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF E) |
|||
MBS1007472-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 555 |
Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF E) |
|||
MBS1007472-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 745 |
Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF E) |
|||
MBS1007472-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 660 |
Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF E) |
|||
MBS1007472-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 870 |
Vascular Endothelial Growth Factor-E (Orf Virus), (Recombinant) |
|||
22060748-1 | Glycomatrix | 2 µg | EUR 146.42 |
Recombinant Vascular Endothelial Growth Factor-E (Orf Virus) |
|||
7-01759 | CHI Scientific | 2µg | Ask for price |
Recombinant Vascular Endothelial Growth Factor-E (Orf Virus) |
|||
7-01760 | CHI Scientific | 10µg | Ask for price |
Recombinant Vascular Endothelial Growth Factor-E (Orf Virus) |
|||
7-01761 | CHI Scientific | 1mg | Ask for price |
Vascular Endothelial Growth Factor-E Recombinant (Orf Virus) |
|||
rAP-2496 | Angio Proteomie | Inquiry | Ask for price |
Recombinant Vascular Endothelial Growth Factor-E (Orf Virus) |
|||
cyt-263-10g | ProSpec Tany | 10µg | EUR 145 |
Recombinant Vascular Endothelial Growth Factor-E (Orf Virus) |
|||
cyt-263-1mg | ProSpec Tany | 1mg | EUR 5100 |
Recombinant Vascular Endothelial Growth Factor-E (Orf Virus) |
|||
cyt-263-2g | ProSpec Tany | 2µg | EUR 60 |
Recombinant Vascular Endothelial Growth Factor-E (Orf Virus) |
|||
MBS142140-0002mg | MyBiosource | 0.002mg | EUR 240 |
Recombinant Vascular Endothelial Growth Factor-E (Orf Virus) |
|||
MBS142140-001mg | MyBiosource | 0.01mg | EUR 310 |
Recombinant Vascular Endothelial Growth Factor-E (Orf Virus) |
|||
MBS142140-1mg | MyBiosource | 1mg | EUR 5325 |
Recombinant Vascular Endothelial Growth Factor-E (Orf Virus) |
|||
MBS142140-5x1mg | MyBiosource | 5x1mg | EUR 23640 |
Hepatitis E Virus ORF3 Protein |
|||
20-abx260138 | Abbexa |
|
|
Hepatitis E Virus ORF3 Protein |
|||
abx260138-20g | Abbexa | 20 µg | EUR 950 |
Hepatitis E Virus ORF3 Protein |
|||
abx260138-5g | Abbexa | 5 µg | EUR 350 |
Hepatitis E virus |
|||
PCR-H498-PCRH49848R | Bioingentech | PCR-H498-48R | EUR 485 |
Hepatitis E virus |
|||
PCR-H498-PCRH49896R | Bioingentech | PCR-H498-96R | EUR 685 |
Hepatitis E virus |
|||
Oneq-H498-OneqH498100R | Bioingentech | Oneq-H498-100R | EUR 1028 |
Hepatitis E virus |
|||
Oneq-H498-OneqH498150R | Bioingentech | Oneq-H498-150R | EUR 1438 |
Hepatitis E virus |
|||
Oneq-H498-OneqH49850R | Bioingentech | Oneq-H498-50R | EUR 728 |
Hepatitis E virus |
|||
MBS328020-01mg | MyBiosource | 0.1mg | EUR 435 |
Hepatitis E virus |
|||
MBS328020-5x01mg | MyBiosource | 5x0.1mg | EUR 1865 |
Hepatitis E virus |
|||
MBS328021-01mg | MyBiosource | 0.1mg | EUR 435 |
Hepatitis E virus |
|||
MBS328021-5x01mg | MyBiosource | 5x0.1mg | EUR 1865 |
Hepatitis E virus |
|||
MBS328022-01mg | MyBiosource | 0.1mg | EUR 435 |
Hepatitis E virus |
|||
MBS328022-5x01mg | MyBiosource | 5x0.1mg | EUR 1865 |
Hepatitis E Virus ORF3 (Recombinant) |
|||
22060181-1 | Glycomatrix | 100 µg | EUR 264.47 |
Recombinant Hepatitis E Virus ORF3 |
|||
7-07450 | CHI Scientific | 100µg | Ask for price |
Recombinant Hepatitis E Virus ORF3 |
|||
7-07451 | CHI Scientific | 500µg | Ask for price |
Recombinant Hepatitis E Virus ORF3 |
|||
7-07452 | CHI Scientific | 1000µg | Ask for price |
Hepatitis E Virus ORF3 Recombinant |
|||
rAP-5321 | Angio Proteomie | Inquiry | Ask for price |
Recombinant Hepatitis E Virus ORF3 |
|||
MBS142588-01mg | MyBiosource | 0.1mg | EUR 330 |
Recombinant Hepatitis E Virus ORF3 |
|||
MBS142588-05mg | MyBiosource | 0.5mg | EUR 825 |
Recombinant Hepatitis E Virus ORF3 |
|||
MBS142588-1mg | MyBiosource | 1mg | EUR 1515 |
Recombinant Hepatitis E Virus ORF3 |
|||
MBS142588-5x1mg | MyBiosource | 5x1mg | EUR 6485 |
Hepatitis E Virus, ORF2, Recombinant (HEV) |
|||
MBS637880-01mg | MyBiosource | 0.1mg | EUR 455 |
Hepatitis E Virus, ORF2, Recombinant (HEV) |
|||
MBS637880-05mg | MyBiosource | 0.5mg | EUR 1025 |
Hepatitis E Virus, ORF2, Recombinant (HEV) |
|||
MBS637880-5x05mg | MyBiosource | 5x0.5mg | EUR 4470 |
Hepatitis E Virus, ORF3, Recombinant (HEV) |
|||
MBS636730-01mg | MyBiosource | 0.1mg | EUR 735 |
Hepatitis E Virus, ORF3, Recombinant (HEV) |
|||
MBS636730-5x01mg | MyBiosource | 5x0.1mg | EUR 3155 |
VEGF (165): Human Recombinant E Coli |
|||
GWB-BDEFEF | GenWay Biotech | 1 mg | Ask for price |
OPPA00528-2UG - VEGF E Protein |
|||
OPPA00528-2UG | Aviva Systems Biology | 2ug | EUR 70 |
Hepatitis E virus (ratHEV) |
|||
Oneq-V372-OneqV372100R | Bioingentech | Oneq-V372-100R | EUR 1028 |
Hepatitis E virus (ratHEV) |
|||
Oneq-V372-OneqV372150R | Bioingentech | Oneq-V372-150R | EUR 1438 |
Hepatitis E virus (ratHEV) |
|||
Oneq-V372-OneqV37250R | Bioingentech | Oneq-V372-50R | EUR 728 |
Hepatitis E virus (ratHEV) |
|||
PCR-V372-PCRV37248R | Bioingentech | PCR-V372-48R | EUR 485 |
Hepatitis E virus (ratHEV) |
|||
PCR-V372-PCRV37296R | Bioingentech | PCR-V372-96R | EUR 685 |
Hepatitis E Virus ORF2 (452-617) Protein |
|||
20-abx260268 | Abbexa |
|
|
Hepatitis E Virus ORF2 (633-659) Protein |
|||
20-abx260269 | Abbexa |
|
|
Hepatitis E Virus ORF2 (403-461) Protein |
|||
20-abx260270 | Abbexa |
|
|
Hepatitis E Virus ORF2 (452-617) Protein |
|||
abx260268-20g | Abbexa | 20 µg | EUR 950 |
Hepatitis E Virus ORF2 (452-617) Protein |
|||
abx260268-5g | Abbexa | 5 µg | EUR 350 |
Hepatitis E Virus ORF2 (633-659) Protein |
|||
abx260269-25g | Abbexa | 25 µg | EUR 950 |
Hepatitis E Virus ORF2 (633-659) Protein |
|||
abx260269-5g | Abbexa | 5 µg | EUR 350 |
Hepatitis E Virus ORF2 (403-461) Protein |
|||
abx260270-25g | Abbexa | 25 µg | EUR 950 |
Hepatitis E Virus ORF2 (403-461) Protein |
|||
abx260270-5g | Abbexa | 5 µg | EUR 350 |
Recombinant Vaccinia virus Uncharacterized 9.3 kDa protein (D ORF E) |
|||
MBS1205850-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1005 |
Recombinant Vaccinia virus Uncharacterized 9.3 kDa protein (D ORF E) |
|||
MBS1205850-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 570 |
Recombinant Vaccinia virus Uncharacterized 9.3 kDa protein (D ORF E) |
|||
MBS1205850-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 755 |
Recombinant Vaccinia virus Uncharacterized 9.3 kDa protein (D ORF E) |
|||
MBS1205850-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 680 |
Recombinant Vaccinia virus Uncharacterized 9.3 kDa protein (D ORF E) |
|||
MBS1205850-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 885 |
Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF D) |
|||
MBS1182981-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 990 |
Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF D) |
|||
MBS1182981-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 555 |
Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF D) |
|||
MBS1182981-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 745 |
Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF D) |
|||
MBS1182981-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 660 |
Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF D) |
|||
MBS1182981-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 870 |
Recombinant Vaccinia virus Uncharacterized 10.5 kDa protein (B ORF E) |
|||
MBS1177237-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1015 |
Recombinant Vaccinia virus Uncharacterized 10.5 kDa protein (B ORF E) |
|||
MBS1177237-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 585 |
Recombinant Vaccinia virus Uncharacterized 10.5 kDa protein (B ORF E) |
|||
MBS1177237-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 770 |
Recombinant Vaccinia virus Uncharacterized 10.5 kDa protein (B ORF E) |
|||
MBS1177237-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 700 |
Recombinant Vaccinia virus Uncharacterized 10.5 kDa protein (B ORF E) |
|||
MBS1177237-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 900 |
Recombinant Vaccinia virus Uncharacterized 7.2 kDa protein (C ORF E) |
|||
MBS1122067-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 990 |
Recombinant Vaccinia virus Uncharacterized 7.2 kDa protein (C ORF E) |
|||
MBS1122067-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 555 |
Recombinant Vaccinia virus Uncharacterized 7.2 kDa protein (C ORF E) |
|||
MBS1122067-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 745 |
Recombinant Vaccinia virus Uncharacterized 7.2 kDa protein (C ORF E) |
|||
MBS1122067-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 660 |
Recombinant Vaccinia virus Uncharacterized 7.2 kDa protein (C ORF E) |
|||
MBS1122067-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 870 |
Recombinant Vaccinia virus Uncharacterized 18.2 kDa protein (A ORF E) |
|||
MBS1108353-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1085 |
Recombinant Vaccinia virus Uncharacterized 18.2 kDa protein (A ORF E) |
|||
MBS1108353-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 680 |
Recombinant Vaccinia virus Uncharacterized 18.2 kDa protein (A ORF E) |
|||
MBS1108353-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 840 |
Recombinant Vaccinia virus Uncharacterized 18.2 kDa protein (A ORF E) |
|||
MBS1108353-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 790 |
Recombinant Vaccinia virus Uncharacterized 18.2 kDa protein (A ORF E) |
|||
MBS1108353-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 985 |
Recombinant Vaccinia virus Uncharacterized 9.3 kDa protein (D ORF E) |
|||
MBS1083094-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1005 |
Recombinant Vaccinia virus Uncharacterized 9.3 kDa protein (D ORF E) |
|||
MBS1083094-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 570 |
Recombinant Vaccinia virus Uncharacterized 9.3 kDa protein (D ORF E) |
|||
MBS1083094-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 755 |
Recombinant Vaccinia virus Uncharacterized 9.3 kDa protein (D ORF E) |
|||
MBS1083094-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 680 |
Recombinant Vaccinia virus Uncharacterized 9.3 kDa protein (D ORF E) |
|||
MBS1083094-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 885 |
Recombinant Vaccinia virus Uncharacterized 12.9 kDa protein (E ORF F) |
|||
MBS1091262-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1040 |
Recombinant Vaccinia virus Uncharacterized 12.9 kDa protein (E ORF F) |
|||
MBS1091262-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 615 |
Recombinant Vaccinia virus Uncharacterized 12.9 kDa protein (E ORF F) |
|||
MBS1091262-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 790 |
Recombinant Vaccinia virus Uncharacterized 12.9 kDa protein (E ORF F) |
|||
MBS1091262-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 715 |
Recombinant Vaccinia virus Uncharacterized 12.9 kDa protein (E ORF F) |
|||
MBS1091262-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 925 |
Recombinant Vaccinia virus Uncharacterized 11.9 kDa protein (E ORF B) |
|||
MBS1249711-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1030 |
Recombinant Vaccinia virus Uncharacterized 11.9 kDa protein (E ORF B) |
|||
MBS1249711-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 605 |
Recombinant Vaccinia virus Uncharacterized 11.9 kDa protein (E ORF B) |
|||
MBS1249711-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 780 |
Recombinant Vaccinia virus Uncharacterized 11.9 kDa protein (E ORF B) |
|||
MBS1249711-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 700 |
Recombinant Vaccinia virus Uncharacterized 11.9 kDa protein (E ORF B) |
|||
MBS1249711-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 915 |
Recombinant Vaccinia virus Uncharacterized 7.8 kDa protein (F ORF E) |
|||
MBS1252431-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 995 |
Recombinant Vaccinia virus Uncharacterized 7.8 kDa protein (F ORF E) |
|||
MBS1252431-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 560 |
Recombinant Vaccinia virus Uncharacterized 7.8 kDa protein (F ORF E) |
|||
MBS1252431-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 750 |
Recombinant Vaccinia virus Uncharacterized 7.8 kDa protein (F ORF E) |
|||
MBS1252431-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 670 |
Recombinant Vaccinia virus Uncharacterized 7.8 kDa protein (F ORF E) |
|||
MBS1252431-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 875 |
Recombinant Vaccinia virus Uncharacterized 8.0 kDa protein (E ORF C) |
|||
MBS1253964-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 995 |
Recombinant Vaccinia virus Uncharacterized 8.0 kDa protein (E ORF C) |
|||
MBS1253964-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 560 |
Recombinant Vaccinia virus Uncharacterized 8.0 kDa protein (E ORF C) |
|||
MBS1253964-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 745 |
Recombinant Vaccinia virus Uncharacterized 8.0 kDa protein (E ORF C) |
|||
MBS1253964-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 665 |
Recombinant Vaccinia virus Uncharacterized 8.0 kDa protein (E ORF C) |
|||
MBS1253964-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 875 |
Recombinant Vaccinia virus Uncharacterized 10.5 kDa protein (B ORF E) |
|||
MBS1229686-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1015 |
Recombinant Vaccinia virus Uncharacterized 10.5 kDa protein (B ORF E) |
|||
MBS1229686-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 585 |
Recombinant Vaccinia virus Uncharacterized 10.5 kDa protein (B ORF E) |
|||
MBS1229686-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 770 |
Recombinant Vaccinia virus Uncharacterized 10.5 kDa protein (B ORF E) |
|||
MBS1229686-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 700 |
Recombinant Vaccinia virus Uncharacterized 10.5 kDa protein (B ORF E) |
|||
MBS1229686-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 900 |
Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF A) |
|||
MBS1215198-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 995 |
Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF A) |
|||
MBS1215198-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 560 |
Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF A) |
|||
MBS1215198-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 750 |
Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF A) |
|||
MBS1215198-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 670 |
Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF A) |
|||
MBS1215198-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 875 |
Hepatitis E Virus protein |
|||
30-AH29 | Fitzgerald | 1 mg | EUR 895 |
Description: Hepatitis E Virus recombinant protein |
Hepatitis E Virus protein |
|||
30R-AH054X | Fitzgerald | 500 ug | EUR 840 |
Description: Hepatitis E Virus Mosaic recombinant protein |
Hepatitis E Virus protein |
|||
MBS537843-05mg | MyBiosource | 0.5mg | EUR 1700 |
Hepatitis E Virus protein |
|||
MBS537843-5x05mg | MyBiosource | 5x0.5mg | EUR 7505 |
Identification and characterization of a cDNA encoding a gametocyte-specific protein of the avian coccidial parasite Eimerianecatrix
Gametocyte proteins of Eimeria spp. are necessary components of the oocyst wall, and some of those proteins have been analysed to ascertain targets of transmission-blocking vaccines in opposition to avian coccidiosis. Within the present study, a cDNA from E. necatrix gametocytes was cloned and sequenced. The cDNA is 1,473 bp in dimension and encodes a 490-amino-acid protein containing a tyrosine-serine (Tyr/Ser)-rich space and a proline-methionine (Professional/Met)-rich space.
A quantitative real-time PCR (qPCR) analysis confirmed that the cDNA is expressed solely all through gametogenesis. A fraction containing the Tyr/Ser-rich space (rEnGAM59) was expressed in Escherichia coli BL21 (DE3) cells. Immunoblotting confirmed that rEnGAM59 was acknowledged by the serum of convalescent chickens after an an infection with E. necatrix, and that an anti-rEnGAM59 antibody acknowledged a ∼59 kDa protein and
two completely different proteins (∼35 kDa and ∼33 kDa) in gametocyte extracts. An immunofluorescence assay confirmed that the anti-rEnGAM59 antibody acknowledged wall-forming our our bodies inside the macrogametocytes and oocyst partitions. An in vivo vaccination and drawback trial was carried out to test the potential utility of rEnGAM59 as a vaccine.
Immunized chickens carried out larger than the unimmunized and challenged (constructive administration) chickens. The intestinal lesion scores have been significantly lower inside the immunized groups than inside the constructive administration group (P < 0.05). In distinction, the physique weight optimistic elements (BWG) have been significantly bigger inside the immunized groups than inside the constructive administration group (P < 0.05). There have been no important variations inside the lesion scores and BWG between the groups immunized with rEnGAM59 protein or with keep oocysts (P > 0.05). Chickens immunized with rEnGAM59 protein had a significantly bigger antigen-specific serum IgY response (P < 0.05). rEnGAM59 protein could be utilized as candidate antigen to develop a recombinant coccidiosis vaccine.
[Reverse genetics of rotaviruses: Generation of recombinant human rotaviruses from just 11 cDNAs encoding the rotavirus genome]
A totally plasmid-based reverse genetics system for animal rotavirus was established very currently. We improved the reverse genetics system to generate recombinant rotavirus by transfecting solely 11 T7 plasmids for its 11 genes under the scenario of accelerating the ratio (3- or 5-fold) of the cDNA plasmids for NSP2 and NSP5 genes (11-plasmid system).
Using this extraordinarily atmosphere pleasant system, we engineered the first infectious recombinant rotaviruses harboring fluorescent (EGFP and mCherry) protein genes. Along with these recombinant animal viruses, the first infectious recombinant human rotavirus (strain KU (G1P[8])) was moreover generated with the 11-plasmid system with some modifications.
The provide of recombinant human rotaviruses will current a genetic platform for a higher understanding of the replication, pathogenicity, and completely different natural traits of this medically important virus and permit the rational enchancment of next-generation human rotavirus vaccines.
CFB Polyclonal Antibody |
|||
MBS127099-002mL | MyBiosource | 0.02mL | EUR 200 |
CFB Polyclonal Antibody |
|||
MBS127099-005mL | MyBiosource | 0.05mL | EUR 255 |
CFB Polyclonal Antibody |
|||
MBS127099-01mL | MyBiosource | 0.1mL | EUR 345 |
CFB Polyclonal Antibody |
|||
MBS127099-02mL | MyBiosource | 0.2mL | EUR 545 |
CFB Polyclonal Antibody |
|||
MBS127099-5x02mL | MyBiosource | 5x0.2mL | EUR 2265 |
CFB Polyclonal Antibody |
|||
A71591 | EpiGentek | 50 μl | EUR 408 |
CFB Polyclonal Antibody |
|||
E-AB-66031-120uL | Elabscience Biotech | 120uL | EUR 320 |
Description: Unconjugated |
CFB Polyclonal Antibody |
|||
E-AB-66031-200uL | Elabscience Biotech | 200uL | EUR 530 |
Description: Unconjugated |
CFB Polyclonal Antibody |
|||
E-AB-66031-60uL | Elabscience Biotech | 60uL | EUR 200 |
Description: Unconjugated |
CFB Polyclonal Antibody |
|||
E-AB-66031-each | Elabscience Biotech | each | Ask for price |
Description: Unconjugated |
CFB Polyclonal Antibody |
|||
MBS9133291-002mL | MyBiosource | 0.02mL | EUR 200 |
CFB Polyclonal Antibody |
|||
MBS9133291-005mL | MyBiosource | 0.05mL | EUR 255 |
CFB Polyclonal Antibody |
|||
MBS9133291-01mL | MyBiosource | 0.1mL | EUR 345 |
CFB Polyclonal Antibody |
|||
MBS9133291-02mL | MyBiosource | 0.2mL | EUR 545 |
CFB Polyclonal Antibody |
|||
MBS9133291-5x02mL | MyBiosource | 5x0.2mL | EUR 2265 |
CFB Polyclonal Antibody |
|||
MBS8567985-01mL | MyBiosource | 0.1mL | EUR 305 |
CFB Polyclonal Antibody |
|||
MBS8567985-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 565 |
CFB Polyclonal Antibody |
|||
MBS8567985-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 565 |
CFB Polyclonal Antibody |
|||
MBS8567985-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 565 |
CFB Polyclonal Antibody |
|||
MBS8567985-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 565 |
CFB Polyclonal Antibody |
|||
MBS2564863-006mL | MyBiosource | 0.06mL | EUR 190 |
CFB Polyclonal Antibody |
|||
MBS2564863-012mL | MyBiosource | 0.12mL | EUR 265 |
CFB Polyclonal Antibody |
|||
MBS2564863-02mL | MyBiosource | 0.2mL | EUR 415 |
CFB Polyclonal Antibody |
|||
MBS2564863-5x02mL | MyBiosource | 5x0.2mL | EUR 1835 |
CFB Polyclonal Antibody |
|||
MBS2562211-002mL | MyBiosource | 0.02mL | EUR 140 |
CFB Polyclonal Antibody |
|||
MBS2562211-006mL | MyBiosource | 0.06mL | EUR 180 |
CFB Polyclonal Antibody |
|||
MBS2562211-012mL | MyBiosource | 0.12mL | EUR 260 |
CFB Polyclonal Antibody |
|||
MBS2562211-02mL | MyBiosource | 0.2mL | EUR 405 |
CFB Polyclonal Antibody |
|||
MBS2562211-5x02mL | MyBiosource | 5x0.2mL | EUR 1725 |
CFB Polyclonal Antibody |
|||
MBS2560281-002mL | MyBiosource | 0.02mL | EUR 140 |
CFB Polyclonal Antibody |
|||
MBS2560281-006mL | MyBiosource | 0.06mL | EUR 180 |
CFB Polyclonal Antibody |
|||
MBS2560281-012mL | MyBiosource | 0.12mL | EUR 260 |
CFB Polyclonal Antibody |
|||
MBS2560281-02mL | MyBiosource | 0.2mL | EUR 405 |
CFB Polyclonal Antibody |
|||
MBS2560281-5x02mL | MyBiosource | 5x0.2mL | EUR 1725 |
CFB Polyclonal Antibody |
|||
RD266031A-120uL | Reddot Biotech | 120μL | EUR 360 |
Description: This gene encodes complement factor B, a component of the alternative pathway of complement activation. Factor B circulates in the blood as a single chain polypeptide. Upon activation of the alternative pathway, it is cleaved by complement factor D yielding the noncatalytic chain Ba and the catalytic subunit Bb. The active subunit Bb is a serine protease which associates with C3b to form the alternative pathway C3 convertase. Bb is involved in the proliferation of preactivated B lymphocytes, while Ba inhibits their proliferation. This gene localizes to the major histocompatibility complex (MHC) class III region on chromosome 6. This cluster includes several genes involved in regulation of the immune reaction. Polymorphisms in this gene are associated with a reduced risk of age-related macular degeneration. The polyadenylation site of this gene is 421 bp from the 5' end of the gene for complement component 2. |
CFB Polyclonal Antibody |
|||
RD266031A-200uL | Reddot Biotech | 200μL | EUR 630 |
Description: This gene encodes complement factor B, a component of the alternative pathway of complement activation. Factor B circulates in the blood as a single chain polypeptide. Upon activation of the alternative pathway, it is cleaved by complement factor D yielding the noncatalytic chain Ba and the catalytic subunit Bb. The active subunit Bb is a serine protease which associates with C3b to form the alternative pathway C3 convertase. Bb is involved in the proliferation of preactivated B lymphocytes, while Ba inhibits their proliferation. This gene localizes to the major histocompatibility complex (MHC) class III region on chromosome 6. This cluster includes several genes involved in regulation of the immune reaction. Polymorphisms in this gene are associated with a reduced risk of age-related macular degeneration. The polyadenylation site of this gene is 421 bp from the 5' end of the gene for complement component 2. |
CFB Polyclonal Antibody |
|||
RD266031A-60uL | Reddot Biotech | 60μL | EUR 204 |
Description: This gene encodes complement factor B, a component of the alternative pathway of complement activation. Factor B circulates in the blood as a single chain polypeptide. Upon activation of the alternative pathway, it is cleaved by complement factor D yielding the noncatalytic chain Ba and the catalytic subunit Bb. The active subunit Bb is a serine protease which associates with C3b to form the alternative pathway C3 convertase. Bb is involved in the proliferation of preactivated B lymphocytes, while Ba inhibits their proliferation. This gene localizes to the major histocompatibility complex (MHC) class III region on chromosome 6. This cluster includes several genes involved in regulation of the immune reaction. Polymorphisms in this gene are associated with a reduced risk of age-related macular degeneration. The polyadenylation site of this gene is 421 bp from the 5' end of the gene for complement component 2. |
CFB Rabbit Polyclonal Antibody |
|||
E10G33450 | EnoGene | 100 μl | EUR 275 |
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
CFB Rabbit Polyclonal Antibody |
|||
E10G09127 | EnoGene | 100 μl | EUR 275 |
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
CFB Rabbit Polyclonal Antibody |
|||
E10G02151 | EnoGene | 100 μl | EUR 275 |
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
CFB Polyclonal Antibody, HRP Conjugated |
|||
A55576 | EpiGentek |
|
|
CFB Polyclonal Antibody, FITC Conjugated |
|||
A55577 | EpiGentek |
|
|
CFB Polyclonal Antibody, Biotin Conjugated |
|||
A55578 | EpiGentek |
|
|
Polyclonal CFB Antibody (Center) |
|||
APR06137G | Leading Biology | 0.1ml | EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human CFB (Center). This antibody is tested and proven to work in the following applications: |
Complement Factor B (CFB) Polyclonal Antibody |
|||
CAU24846-100ul | Biomatik Corporation | 100ul | EUR 255.4 |
Complement Factor B (CFB) Polyclonal Antibody |
|||
CAU24846-200ul | Biomatik Corporation | 200ul | EUR 319.2 |
Complement Factor B (CFB) Polyclonal Antibody |
|||
CAU24847-100ul | Biomatik Corporation | 100ul | EUR 255.4 |
Complement Factor B (CFB) Polyclonal Antibody |
|||
CAU24847-200ul | Biomatik Corporation | 200ul | EUR 319.2 |
Complement Factor B (CFB) Polyclonal Antibody |
|||
CAU24848-100ul | Biomatik Corporation | 100ul | EUR 255.4 |
Complement Factor B (CFB) Polyclonal Antibody |
|||
CAU24848-200ul | Biomatik Corporation | 200ul | EUR 319.2 |
Complement Factor B (CFB) Polyclonal Antibody |
|||
CAU24849-100ul | Biomatik Corporation | 100ul | EUR 255.4 |
Complement Factor B (CFB) Polyclonal Antibody |
|||
CAU24849-200ul | Biomatik Corporation | 200ul | EUR 319.2 |
Complement Factor B (CFB) Polyclonal Antibody |
|||
CAU24850-100ul | Biomatik Corporation | 100ul | EUR 241.9 |
Complement Factor B (CFB) Polyclonal Antibody |
|||
CAU24850-200ul | Biomatik Corporation | 200ul | EUR 302.4 |
Complement Factor B (CFB) Polyclonal Antibody |
|||
CAU24851-100ul | Biomatik Corporation | 100ul | EUR 241.9 |
Complement Factor B (CFB) Polyclonal Antibody |
|||
CAU24851-200ul | Biomatik Corporation | 200ul | EUR 302.4 |
Complement Factor B (CFB) Polyclonal Antibody |
|||
CAU24852-100ul | Biomatik Corporation | 100ul | EUR 235.2 |
Complement Factor B (CFB) Polyclonal Antibody |
|||
CAU24852-200ul | Biomatik Corporation | 200ul | EUR 294 |
Complement Factor B (CFB) Polyclonal Antibody |
|||
CAU24853-100ul | Biomatik Corporation | 100ul | EUR 235.2 |
Complement Factor B (CFB) Polyclonal Antibody |
|||
CAU24853-200ul | Biomatik Corporation | 200ul | EUR 294 |
Complement Factor B (CFB) Polyclonal Antibody |
|||
CAU24854-100ul | Biomatik Corporation | 100ul | EUR 235.2 |
Complement Factor B (CFB) Polyclonal Antibody |
|||
CAU24854-200ul | Biomatik Corporation | 200ul | EUR 294 |
Complement Factor B (CFB) Polyclonal Antibody (Rat) |
|||
4-PAC011Ra01 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Rat Complement Factor B (CFB) |
Complement Factor B (CFB) Polyclonal Antibody (Rat) |
|||
4-PAC011Ra02 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Rat Complement Factor B (CFB) |
Complement Factor B (CFB) Polyclonal Antibody (Rat) |
|||
4-PAC011Ra04 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Rat Complement Factor B (CFB) |
Complement Factor B (CFB) Polyclonal Antibody (Human) |
|||
4-PAC011Hu01 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Complement Factor B (CFB) |
Complement Factor B (CFB) Polyclonal Antibody (Human) |
|||
4-PAC011Hu02 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Complement Factor B (CFB) |
Complement Factor B (CFB) Polyclonal Antibody (Human) |
|||
4-PAC011Hu03 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Complement Factor B (CFB) |
Complement Factor B (CFB) Polyclonal Antibody (Mouse) |
|||
4-PAC011Mu01 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Mouse Complement Factor B (CFB) |
Complement Factor B (CFB) Polyclonal Antibody (Rat), PE |
|||
4-PAC011Ra01-PE | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Rat Complement Factor B (CFB). This antibody is labeled with PE. |
Complement Factor B (CFB) Polyclonal Antibody (Rat), PE |
|||
4-PAC011Ra02-PE | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Rat Complement Factor B (CFB). This antibody is labeled with PE. |
Complement Factor B (CFB) Polyclonal Antibody (Rat), PE |
|||
4-PAC011Ra04-PE | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Rat Complement Factor B (CFB). This antibody is labeled with PE. |
Complement Factor B (CFB) Polyclonal Antibody (Rat), APC |
|||
4-PAC011Ra01-APC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Rat Complement Factor B (CFB). This antibody is labeled with APC. |
Complement Factor B (CFB) Polyclonal Antibody (Rat), Cy3 |
|||
4-PAC011Ra01-Cy3 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Rat Complement Factor B (CFB). This antibody is labeled with Cy3. |
Complement Factor B (CFB) Polyclonal Antibody (Rat), HRP |
|||
4-PAC011Ra01-HRP | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Rat Complement Factor B (CFB). This antibody is labeled with HRP. |
Complement Factor B (CFB) Polyclonal Antibody (Rat), APC |
|||
4-PAC011Ra02-APC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Rat Complement Factor B (CFB). This antibody is labeled with APC. |
Complement Factor B (CFB) Polyclonal Antibody (Rat), Cy3 |
|||
4-PAC011Ra02-Cy3 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Rat Complement Factor B (CFB). This antibody is labeled with Cy3. |
Complement Factor B (CFB) Polyclonal Antibody (Rat), HRP |
|||
4-PAC011Ra02-HRP | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Rat Complement Factor B (CFB). This antibody is labeled with HRP. |
Complement Factor B (CFB) Polyclonal Antibody (Rat), APC |
|||
4-PAC011Ra04-APC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Rat Complement Factor B (CFB). This antibody is labeled with APC. |
Complement Factor B (CFB) Polyclonal Antibody (Rat), Cy3 |
|||
4-PAC011Ra04-Cy3 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Rat Complement Factor B (CFB). This antibody is labeled with Cy3. |
Complement Factor B (CFB) Polyclonal Antibody (Rat), HRP |
|||
4-PAC011Ra04-HRP | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Rat Complement Factor B (CFB). This antibody is labeled with HRP. |
Complement Factor B (CFB) Polyclonal Antibody (Human), PE |
|||
4-PAC011Hu01-PE | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Complement Factor B (CFB). This antibody is labeled with PE. |
Complement Factor B (CFB) Polyclonal Antibody (Human), PE |
|||
4-PAC011Hu02-PE | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Complement Factor B (CFB). This antibody is labeled with PE. |
Complement Factor B (CFB) Polyclonal Antibody (Human), PE |
|||
4-PAC011Hu03-PE | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Complement Factor B (CFB). This antibody is labeled with PE. |
Complement Factor B (CFB) Polyclonal Antibody (Mouse), PE |
|||
4-PAC011Mu01-PE | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Mouse Complement Factor B (CFB). This antibody is labeled with PE. |
Complement Factor B (CFB) Polyclonal Antibody (Rat), FITC |
|||
4-PAC011Ra01-FITC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Rat Complement Factor B (CFB). This antibody is labeled with FITC. |
Complement Factor B (CFB) Polyclonal Antibody (Rat), FITC |
|||
4-PAC011Ra02-FITC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Rat Complement Factor B (CFB). This antibody is labeled with FITC. |
Complement Factor B (CFB) Polyclonal Antibody (Rat), FITC |
|||
4-PAC011Ra04-FITC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Rat Complement Factor B (CFB). This antibody is labeled with FITC. |
Complement Factor B (CFB) Polyclonal Antibody (Human), APC |
|||
4-PAC011Hu01-APC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Complement Factor B (CFB). This antibody is labeled with APC. |
Complement Factor B (CFB) Polyclonal Antibody (Human), Cy3 |
|||
4-PAC011Hu01-Cy3 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Complement Factor B (CFB). This antibody is labeled with Cy3. |
Complement Factor B (CFB) Polyclonal Antibody (Human), HRP |
|||
4-PAC011Hu01-HRP | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Complement Factor B (CFB). This antibody is labeled with HRP. |
Complement Factor B (CFB) Polyclonal Antibody (Human), APC |
|||
4-PAC011Hu02-APC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Complement Factor B (CFB). This antibody is labeled with APC. |
Complement Factor B (CFB) Polyclonal Antibody (Human), Cy3 |
|||
4-PAC011Hu02-Cy3 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Complement Factor B (CFB). This antibody is labeled with Cy3. |
Complement Factor B (CFB) Polyclonal Antibody (Human), HRP |
|||
4-PAC011Hu02-HRP | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Complement Factor B (CFB). This antibody is labeled with HRP. |
Complement Factor B (CFB) Polyclonal Antibody (Human), APC |
|||
4-PAC011Hu03-APC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Complement Factor B (CFB). This antibody is labeled with APC. |
Complement Factor B (CFB) Polyclonal Antibody (Human), Cy3 |
|||
4-PAC011Hu03-Cy3 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Complement Factor B (CFB). This antibody is labeled with Cy3. |
Complement Factor B (CFB) Polyclonal Antibody (Human), HRP |
|||
4-PAC011Hu03-HRP | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Complement Factor B (CFB). This antibody is labeled with HRP. |
Complement Factor B (CFB) Polyclonal Antibody (Mouse), APC |
|||
4-PAC011Mu01-APC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Mouse Complement Factor B (CFB). This antibody is labeled with APC. |
Complement Factor B (CFB) Polyclonal Antibody (Mouse), Cy3 |
|||
4-PAC011Mu01-Cy3 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Mouse Complement Factor B (CFB). This antibody is labeled with Cy3. |
Complement Factor B (CFB) Polyclonal Antibody (Mouse), HRP |
|||
4-PAC011Mu01-HRP | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Mouse Complement Factor B (CFB). This antibody is labeled with HRP. |
Complement Factor B (CFB) Polyclonal Antibody (Mouse, Rat) |
|||
4-PAC011Mu02 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Mouse, Rat Complement Factor B (CFB) |
Complement Factor B (CFB) Polyclonal Antibody (Mouse, Rat) |
|||
4-PAC011Ra03 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Mouse, Rat Complement Factor B (CFB) |
Rabbit anti-Mus musculus (Mouse) Cfb Polyclonal Antibody |
|||
MBS7138513-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Complement Factor B (CFB) Polyclonal Antibody (Human), FITC |
|||
4-PAC011Hu01-FITC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Complement Factor B (CFB). This antibody is labeled with FITC. |
Complement Factor B (CFB) Polyclonal Antibody (Human), FITC |
|||
4-PAC011Hu02-FITC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Complement Factor B (CFB). This antibody is labeled with FITC. |
Complement Factor B (CFB) Polyclonal Antibody (Human), FITC |
|||
4-PAC011Hu03-FITC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Complement Factor B (CFB). This antibody is labeled with FITC. |
Complement Factor B (CFB) Polyclonal Antibody (Mouse), FITC |
|||
4-PAC011Mu01-FITC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Mouse Complement Factor B (CFB). This antibody is labeled with FITC. |
Polyclonal CFB / Complement Factor B Antibody |
|||
APG01178G | Leading Biology | 0.1ml | EUR 580.8 |
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human CFB / Complement Factor B . This antibody is tested and proven to work in the following applications: |
Polyclonal Antibody to Complement Factor B (CFB) |
|||
PAC011Hu01 | Cloud-Clone | 100ul | EUR 245 |
Polyclonal Antibody to Complement Factor B (CFB) |
|||
PAC011Hu02 | Cloud-Clone | 100ul | EUR 245 |
Polyclonal Antibody to Complement Factor B (CFB) |
|||
PAC011Hu03 | Cloud-Clone | 100ul | EUR 245 |
Polyclonal Antibody to Complement Factor B (CFB) |
|||
PAC011Hu04 | Cloud-Clone | 100ul | EUR 252 |
Polyclonal Antibody to Complement Factor B (CFB) |
|||
PAC011Mu02 | Cloud-Clone | 100ul | EUR 252 |
Polyclonal Antibody to Complement Factor B (CFB) |
|||
PAC011Ra01 | Cloud-Clone | 100ul | EUR 266 |
Polyclonal Antibody to Complement Factor B (CFB) |
|||
PAC011Ra02 | Cloud-Clone | 100ul | EUR 266 |
Polyclonal Antibody to Complement Factor B (CFB) |
|||
PAC011Ra03 | Cloud-Clone | 100ul | EUR 266 |
Polyclonal Antibody to Complement Factor B (CFB) |
|||
PAC011Ra04 | Cloud-Clone | 100ul | EUR 266 |
Polyclonal Antibody to Complement Factor B (CFB) |
|||
MBS2003025-01mL | MyBiosource | 0.1mL | EUR 175 |
Polyclonal Antibody to Complement Factor B (CFB) |
|||
MBS2003025-02mL | MyBiosource | 0.2mL | EUR 220 |
Polyclonal Antibody to Complement Factor B (CFB) |
|||
MBS2003025-05mL | MyBiosource | 0.5mL | EUR 355 |
Polyclonal Antibody to Complement Factor B (CFB) |
|||
MBS2003025-1mL | MyBiosource | 1mL | EUR 435 |
Polyclonal Antibody to Complement Factor B (CFB) |
|||
MBS2003025-5mL | MyBiosource | 5mL | EUR 1185 |
Polyclonal Antibody to Complement Factor B (CFB) |
|||
MBS2003111-01mL | MyBiosource | 0.1mL | EUR 175 |
Polyclonal Antibody to Complement Factor B (CFB) |
|||
MBS2003111-02mL | MyBiosource | 0.2mL | EUR 220 |
Polyclonal Antibody to Complement Factor B (CFB) |
|||
MBS2003111-05mL | MyBiosource | 0.5mL | EUR 355 |
Polyclonal Antibody to Complement Factor B (CFB) |
|||
MBS2003111-1mL | MyBiosource | 1mL | EUR 435 |
Polyclonal Antibody to Complement Factor B (CFB) |
|||
MBS2003111-5mL | MyBiosource | 5mL | EUR 1185 |
Polyclonal Antibody to Complement Factor B (CFB) |
|||
MBS2004783-01mL | MyBiosource | 0.1mL | EUR 180 |
Polyclonal Antibody to Complement Factor B (CFB) |
|||
MBS2004783-02mL | MyBiosource | 0.2mL | EUR 225 |
Polyclonal Antibody to Complement Factor B (CFB) |
|||
MBS2004783-05mL | MyBiosource | 0.5mL | EUR 380 |
Polyclonal Antibody to Complement Factor B (CFB) |
|||
MBS2004783-1mL | MyBiosource | 1mL | EUR 465 |
Polyclonal Antibody to Complement Factor B (CFB) |
|||
MBS2004783-5mL | MyBiosource | 5mL | EUR 1285 |
Polyclonal Antibody to Complement Factor B (CFB) |
|||
MBS2005919-01mL | MyBiosource | 0.1mL | EUR 175 |
Polyclonal Antibody to Complement Factor B (CFB) |
|||
MBS2005919-02mL | MyBiosource | 0.2mL | EUR 220 |
Polyclonal Antibody to Complement Factor B (CFB) |
|||
MBS2005919-05mL | MyBiosource | 0.5mL | EUR 365 |
Polyclonal Antibody to Complement Factor B (CFB) |
|||
MBS2005919-1mL | MyBiosource | 1mL | EUR 445 |
Polyclonal Antibody to Complement Factor B (CFB) |
|||
MBS2005919-5mL | MyBiosource | 5mL | EUR 1220 |
Polyclonal Antibody to Complement Factor B (CFB) |
|||
MBS2028598-01mL | MyBiosource | 0.1mL | EUR 180 |
Polyclonal Antibody to Complement Factor B (CFB) |
|||
MBS2028598-02mL | MyBiosource | 0.2mL | EUR 225 |
Polyclonal Antibody to Complement Factor B (CFB) |
|||
MBS2028598-05mL | MyBiosource | 0.5mL | EUR 380 |
Polyclonal Antibody to Complement Factor B (CFB) |
|||
MBS2028598-1mL | MyBiosource | 1mL | EUR 465 |
Polyclonal Antibody to Complement Factor B (CFB) |
|||
MBS2028598-5mL | MyBiosource | 5mL | EUR 1285 |
Polyclonal Antibody to Complement Factor B (CFB) |
|||
MBS2139636-01mL | MyBiosource | 0.1mL | EUR 175 |
Polyclonal Antibody to Complement Factor B (CFB) |
|||
MBS2139636-02mL | MyBiosource | 0.2mL | EUR 220 |
Polyclonal Antibody to Complement Factor B (CFB) |
|||
MBS2139636-05mL | MyBiosource | 0.5mL | EUR 365 |
Polyclonal Antibody to Complement Factor B (CFB) |
|||
MBS2139636-1mL | MyBiosource | 1mL | EUR 445 |
Polyclonal Antibody to Complement Factor B (CFB) |
|||
MBS2139636-5mL | MyBiosource | 5mL | EUR 1220 |
Polyclonal Antibody to Complement Factor B (CFB) |
|||
MBS2001426-01mL | MyBiosource | 0.1mL | EUR 180 |
Polyclonal Antibody to Complement Factor B (CFB) |
|||
MBS2001426-02mL | MyBiosource | 0.2mL | EUR 225 |
Polyclonal Antibody to Complement Factor B (CFB) |
|||
MBS2001426-05mL | MyBiosource | 0.5mL | EUR 380 |
Polyclonal Antibody to Complement Factor B (CFB) |
|||
MBS2001426-1mL | MyBiosource | 1mL | EUR 465 |
Polyclonal Antibody to Complement Factor B (CFB) |
|||
MBS2001426-5mL | MyBiosource | 5mL | EUR 1285 |
Polyclonal Antibody to Complement Factor B (CFB) |
|||
MBS2007078-01mL | MyBiosource | 0.1mL | EUR 180 |
Polyclonal Antibody to Complement Factor B (CFB) |
|||
MBS2007078-02mL | MyBiosource | 0.2mL | EUR 225 |
Polyclonal Antibody to Complement Factor B (CFB) |
|||
MBS2007078-05mL | MyBiosource | 0.5mL | EUR 380 |
Polyclonal Antibody to Complement Factor B (CFB) |
|||
MBS2007078-1mL | MyBiosource | 1mL | EUR 465 |
Polyclonal Antibody to Complement Factor B (CFB) |
|||
MBS2007078-5mL | MyBiosource | 5mL | EUR 1285 |
Polyclonal Antibody to Complement Factor B (CFB) |
|||
MBS2007112-01mL | MyBiosource | 0.1mL | EUR 175 |
Polyclonal Antibody to Complement Factor B (CFB) |
|||
MBS2007112-02mL | MyBiosource | 0.2mL | EUR 220 |
Polyclonal Antibody to Complement Factor B (CFB) |
|||
MBS2007112-05mL | MyBiosource | 0.5mL | EUR 355 |
Polyclonal Antibody to Complement Factor B (CFB) |
|||
MBS2007112-1mL | MyBiosource | 1mL | EUR 435 |
Polyclonal Antibody to Complement Factor B (CFB) |
|||
MBS2007112-5mL | MyBiosource | 5mL | EUR 1185 |
Polyclonal Antibody to Complement Factor B (CFB) |
|||
MBS2005049-01mL | MyBiosource | 0.1mL | EUR 175 |
Polyclonal Antibody to Complement Factor B (CFB) |
|||
MBS2005049-02mL | MyBiosource | 0.2mL | EUR 220 |
Polyclonal Antibody to Complement Factor B (CFB) |
|||
MBS2005049-05mL | MyBiosource | 0.5mL | EUR 365 |